201 related articles for article (PubMed ID: 33397733)
1. Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis.
Baker JF; England BR; George M; Cannon G; Sauer B; Ogdie A; Hamilton BC; Hunter C; Duryee MJ; Thiele G; Mikuls TR
Ann Rheum Dis; 2021 May; 80(5):566-572. PubMed ID: 33397733
[TBL] [Abstract][Full Text] [Related]
2. Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort.
England BR; Campany M; Sayles H; Roul P; Yang Y; Ganti AK; Sokolove J; Robinson WH; Reimold AM; Kerr GS; Cannon GW; Sauer BC; Baker JF; Thiele GM; Mikuls TR
Int Immunopharmacol; 2021 Aug; 97():107719. PubMed ID: 33933845
[TBL] [Abstract][Full Text] [Related]
3. Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis.
Ozen G; Pedro S; Holmqvist ME; Avery M; Wolfe F; Michaud K
Ann Rheum Dis; 2017 May; 76(5):848-854. PubMed ID: 27836820
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid Arthritis Disease Activity Predicting Incident Clinically Apparent Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Prospective Cohort Study.
Sparks JA; He X; Huang J; Fletcher EA; Zaccardelli A; Friedlander HM; Gill RR; Hatabu H; Nishino M; Murphy DJ; Iannaccone CK; Mahmoud TG; Frits ML; Lu B; Rosas IO; Dellaripa PF; Weinblatt ME; Karlson EW; Shadick NA; Doyle TJ
Arthritis Rheumatol; 2019 Sep; 71(9):1472-1482. PubMed ID: 30951251
[TBL] [Abstract][Full Text] [Related]
5. Post-traumatic stress disorder and serum cytokine and chemokine concentrations in patients with rheumatoid arthritis
Maloley PM; England BR; Sayles H; Thiele GM; Michaud K; Sokolove J; Cannon GW; Reimold AM; Kerr GS; Baker JF; Caplan L; Case AJ; Mikuls TR
Semin Arthritis Rheum; 2019 Oct; 49(2):229-235. PubMed ID: 30777365
[TBL] [Abstract][Full Text] [Related]
6. Risk of Incident Type 2 Diabetes Mellitus Among Patients With Rheumatoid Arthritis: A Population-Based Cohort Study.
Jin Y; Chen SK; Liu J; Kim SC
Arthritis Care Res (Hoboken); 2020 Sep; 72(9):1248-1256. PubMed ID: 32754989
[TBL] [Abstract][Full Text] [Related]
7. Associations between Adiponectin and the Development of Diabetes in Rheumatoid Arthritis.
Baker JF; England BR; Wysham KD; Sauer B; Joseph AM; Lenert A; Roul P; Xiao R; Gillcrist R; Johnson T; Cannon GW; Duryee M; Thiele GM; Mikuls TR
J Clin Endocrinol Metab; 2024 Jan; ():. PubMed ID: 38189426
[TBL] [Abstract][Full Text] [Related]
8. Associations of Circulating Cytokines and Chemokines With Cancer Mortality in Men With Rheumatoid Arthritis.
England BR; Sokolove J; Robinson WH; Thiele GM; Ganti AK; Sayles H; Michaud K; Caplan L; Davis LA; Cannon GW; Sauer B; Singh N; Blair Solow E; Reimold AM; Kerr GS; Schwab P; Baker JF; Mikuls TR
Arthritis Rheumatol; 2016 Oct; 68(10):2394-402. PubMed ID: 27111000
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis.
Lillegraven S; Greenberg JD; Reed GW; Saunders K; Curtis JR; Harrold L; Hochberg MC; Pappas DA; Kremer JM; Solomon DH
PLoS One; 2019; 14(1):e0210459. PubMed ID: 30673733
[TBL] [Abstract][Full Text] [Related]
10. Monitoring C-reactive protein levels to predict favourable clinical outcomes from tocilizumab treatment in patients with rheumatoid arthritis.
Kojima T; Yabe Y; Kaneko A; Hirano Y; Ishikawa H; Hayashi M; Miyake H; Takagi H; Kato T; Terabe K; Wanatabe T; Tsuchiya H; Kida D; Shioura T; Funahashi K; Kato D; Matsubara H; Takahashi N; Hattori Y; Asai N; Ishiguro N
Mod Rheumatol; 2013 Sep; 23(5):977-85. PubMed ID: 23099471
[TBL] [Abstract][Full Text] [Related]
11. Diabetes mellitus risk in rheumatoid arthritis: reduced incidence with anti-tumor necrosis factor α therapy.
Antohe JL; Bili A; Sartorius JA; Kirchner HL; Morris SJ; Dancea S; Wasko MC
Arthritis Care Res (Hoboken); 2012 Feb; 64(2):215-21. PubMed ID: 21972198
[TBL] [Abstract][Full Text] [Related]
12. Serum cytokine and periodontal profiles in relation to disease activity of rheumatoid arthritis in Japanese adults.
Kobayashi T; Murasawa A; Komatsu Y; Yokoyama T; Ishida K; Abe A; Yamamoto K; Yoshie H
J Periodontol; 2010 May; 81(5):650-7. PubMed ID: 20429644
[TBL] [Abstract][Full Text] [Related]
13. The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.
Shadick NA; Gerlanc NM; Frits ML; Stolshek BS; Brady BL; Iannaccone C; Collier D; Cui J; Mutebi A; Weinblatt ME
Clin Rheumatol; 2019 Nov; 38(11):3081-3092. PubMed ID: 31353421
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of cytokine profiles in rheumatoid arthritis patients with clinically active disease and normal inflammatory indices.
Alex AM; Sayles H; Mikuls TR; Kerr GS
Clin Rheumatol; 2019 Apr; 38(4):1075-1081. PubMed ID: 30506404
[TBL] [Abstract][Full Text] [Related]
15. Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis.
Johnson TM; Sayles HR; Baker JF; George MD; Roul P; Zheng C; Sauer B; Liao KP; Anderson DR; Mikuls TR; England BR
Ann Rheum Dis; 2021 Nov; 80(11):1385-1392. PubMed ID: 34049859
[TBL] [Abstract][Full Text] [Related]
16. Heart Failure Risk Associated With Rheumatoid Arthritis-Related Chronic Inflammation.
Ahlers MJ; Lowery BD; Farber-Eger E; Wang TJ; Bradham W; Ormseth MJ; Chung CP; Stein CM; Gupta DK
J Am Heart Assoc; 2020 May; 9(10):e014661. PubMed ID: 32378457
[TBL] [Abstract][Full Text] [Related]
17. The number of elevated cytokines and chemokines in preclinical seropositive rheumatoid arthritis predicts time to diagnosis in an age-dependent manner.
Deane KD; O'Donnell CI; Hueber W; Majka DS; Lazar AA; Derber LA; Gilliland WR; Edison JD; Norris JM; Robinson WH; Holers VM
Arthritis Rheum; 2010 Nov; 62(11):3161-72. PubMed ID: 20597112
[TBL] [Abstract][Full Text] [Related]
18. Serum chemerin levels: A potential biomarker of joint inflammation in women with rheumatoid arthritis.
Gonzalez-Ponce F; Gamez-Nava JI; Perez-Guerrero EE; Saldaña-Cruz AM; Vazquez-Villegas ML; Ponce-Guarneros JM; Huerta M; Trujillo X; Contreras-Haro B; Rocha-Muñoz AD; Carrillo-Escalante MO; Sanchez-Rodriguez EN; Gomez-Ramirez EE; Nava-Valdivia CA; Cardona-Muñoz EG; Gonzalez-Lopez L;
PLoS One; 2021; 16(9):e0255854. PubMed ID: 34506500
[TBL] [Abstract][Full Text] [Related]
19. Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis.
Solomon DH; Massarotti E; Garg R; Liu J; Canning C; Schneeweiss S
JAMA; 2011 Jun; 305(24):2525-31. PubMed ID: 21693740
[TBL] [Abstract][Full Text] [Related]
20. Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.
Liu W; Zhang Y; Zhu W; Ma C; Ruan J; Long H; Wang Y
Front Immunol; 2018; 9():2228. PubMed ID: 30319663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
